Using data from The Cancer Genome Atlas (TCGA) made available through the Human Protein Atlas (https://www.proteinatlas.org/), we initially verified the prognostic value of CD105 in human RCC; this data showed that patients that have high expression of CD105 demonstrated an overall lower survival probability (Figure 1A). Here, ENG is linked to renal cell carcinoma.